Substance use at admission to an acute psychiatric department

References

• Schiller MJ, Shumway M, Batki SL. Patterns of substance use among patients in an urban psychiatric emergency service. Psychiatr Serv 2000; 51: 113–5
   PubMed Web of Science ®Google Scholar
• Lejoyeux M, Boulenguiez S, Fichelle A, McLoughlin M, Claudon M, Ades J. Alcohol dependence among patients admitted to psychiatric emergency services. Gen Hosp Psychiatry 2000; 22: 206–12
   PubMedGoogle Scholar
• Bonsack C, Camus D, Kaufmann N, Aubert AC, Besson J, Baumann P, et al. Prevalence of substance use in a Swiss psychiatric hospital: Interview reports and urine screening. Addict Behav 2006; 31: 1252–8
   PubMed Web of Science ®Google Scholar
• Hansen SS, Munk-Jorgensen P, Guldbaek B, Solgard T, Lauszus KS, Albrechtsen N, et al. Psychoactive substance use diagnoses among psychiatric in-patients. Acta Psychiatr Scand 2000; 102: 432–8
   PubMed Web of Science ®Google Scholar
• Vaaler AE, Morken G, Flovig JC, Iversen VC, Linaker AM. Substance abuse and recovery in a psychiatric intensive care unit. General Hospital Psychiatry 2006; 28: 65–70
   Google Scholar
• Ries RK, Russo J, Wingerson D, Snowden M, Comtois KA, Srebnik D, et al. Shorter hospital stays and more rapid improvement among patients with schizophrenia and substance disorders. Psychiatr Serv 2000; 51: 210–5
   PubMed Web of Science ®Google Scholar
• Szuster RR, Schanbacher BL, McCann SC, McConnell A. Underdiagnosis of psychoactive-substance-induced organic mental disorders in emergency psychiatry. Am J Drug Alcohol Abuse 1990; 16: 319–27
   PubMed Web of Science ®Google Scholar
• Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8–19
   PubMed Web of Science ®Google Scholar
• Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe—A critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005; 15: 357–76
   PubMed Web of Science ®Google Scholar
• Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264: 2511–8
   PubMed Web of Science ®Google Scholar
• Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2007; 64: 566–76
   PubMed Web of Science ®Google Scholar
• Lambert MT, Griffith JM, Hendrickse W. Characteristics of patients with substance abuse diagnoses on a general psychiatry unit in a VA Medical Center. Psychiatr Serv 1996; 47: 1104–7
   PubMed Web of Science ®Google Scholar
• Mueser KT, Yarnold PR, Rosenberg SD, Swett C, Miles KM, Hill D. Substance use disorder in hospitalized severely mentally ill psychiatric patients: Prevalence, correlates, and subgroups. Schizophr Bull 2000; 26: 179–92
   PubMed Web of Science ®Google Scholar
• Ananth J, Vandewater S, Kamal M, Brodsky A, Gamal R, Miller M. Missed diagnosis of substance abuse in psychiatric patients. Hosp Community Psychiatry 1989; 40: 297–9
   PubMedGoogle Scholar
• Ries RK, Demirsoy A, Russo JE, Barrett J, Roy-Byrne PP. Reliability and clinical utility of DSM-IV substance-induced psychiatric disorders in acute psychiatric inpatients. Am J Addict 2001; 10: 4
   Google Scholar
• Way BB, Allen MH, Mumpower JL, Stewart TR, Banks SM. Interrater agreement among psychiatrist in psychiatric emergency assessments. Am J Psychiatry 1998; 155: 1423–8
   Google Scholar
• EMCDDA. Annual report 2006: The state of the drugs problem in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2006.
   Google Scholar
• McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 1980; 168: 26–33
   PubMed Web of Science ®Google Scholar
• Saunders JB, Aasland OG, Babor TF, de lF, Jr., Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption—II. Addiction 1993;88:791–804.
   Google Scholar
• Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res 2005; 11: 22–31
   PubMed Web of Science ®Google Scholar
• Rehm J, Room R, van den Brink W, Kraus L. Problematic drug use and drug use disorders in EU countries and Norway: An overview of the epidemiology. Eur Neuropsychopharmacol 2005; 15: 389–97
   PubMed Web of Science ®Google Scholar
• Frischer M, Hickman M, Kraus L, Mariani F, Wiessing L. A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain. Addiction 2001; 96: 1465–76
   PubMed Web of Science ®Google Scholar
• Hammett-Stabler CA, Pesce AJ, Cannon DJ. Urine drug screening in the medical setting. Clinica Chimica Acta 2002; 315: 125–35
   PubMed Web of Science ®Google Scholar
• Ley A, Jeffery D, Ruiz J, McLaren S, Gillespie C. Underdetection of comorbid drug use at acute psychiatric admission. Psychiatr Bull R Coll Psychiatr 2002; 26: 248–51
   Google Scholar
• Perrone J, De Roos F, Jayaraman S, Hollander JE. Drug screening versus history in detection of substance use in ED psychiatric patients. Am J Emerg Med 2001; 19: 49–51
   PubMed Web of Science ®Google Scholar
• Schiller MJ, Shumway M, Batki SL. Utility of routine drug screening in a psychiatric emergency setting. Psychiatr Serv 2000; 51: 474–8
   PubMed Web of Science ®Google Scholar
• Claassen CA, Gilfillan S, Orsulak P, Carmody TJ, Battaglia J, Rush AJ. Substance use among patients with a psychotic disorder in a psychiatric emergency room. Psychiatr Serv 1997; 48: 353–8
   PubMed Web of Science ®Google Scholar
• Elangovan N, Berman S, Meinzer A, Gianelli P, Miller H, Longmore W. Substance abuse among patients presenting at an inner-city psychiatric emergency room. Hosp Community Psychiatry 1993; 44: 782–4
   PubMedGoogle Scholar
• Clayton RR, Voss HL, Robbins C, Skinner WF. Gender difference in drug use: An epidemiological perspective. In: Ray BA, Braude MC. NIDA Research Monograph 65: Women and Drugs: A New Era of Research. National Institute on Drug Abuse; 1986. p. 81–99.
   Google Scholar
• Magrini N, Vaccheri A, Parma E, D'Alessandro R, Bottoni A, Occhionero M, et al. Use of benzodiazepines in the Italian general population: Prevalence, pattern of use and risk factors for use. Eur J Clin Pharmacol 1996; 50: 19–25
   PubMed Web of Science ®Google Scholar
• van Hulten R, Leufkens HG, Bakker A. Usage patterns of benzodiazepines in a Dutch community: A 10-year follow-up. Pharm World Sci 1998; 20: 78–82
   PubMed Web of Science ®Google Scholar
• Zandstra SM, Furer JW, van de Lisdonk EH, van't Hof M, Bor JH, van Weel C, et al. Different study criteria affect the prevalence of benzodiazepine use. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 139–44
   PubMed Web of Science ®Google Scholar
• World Health Organization. The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research. GenevaSwitzerland: World Health Organization; 1993.
   Google Scholar
• Tsuno N, Besset A, Ritchie K. Sleep and depression. J Clin Psychiatry 2005; 66: 1254–69
   PubMed Web of Science ®Google Scholar
• Miele GM, Carpenter KM, Cockerham MS, Trautman KD, Blaine J, Hasin DS. Substance Dependence Severity Scale—Reliability and validity for ICD-10 substance use disorders. Addictive Behaviors 2001; 26: 603–12
   PubMed Web of Science ®Google Scholar
• Szuster RR, Schanbacher BL, McCann SC. Characteristics of psychiatric emergency room patients with alcohol- or drug-induced disorders. Hosp Community Psychiatry 1990; 41: 1342–5
   PubMedGoogle Scholar
• Kringlen E, Torgersen S, Cramer V. A Norwegian psychiatric epidemiological study. Am J Psychiatry 2001; 158: 1091–8
   PubMed Web of Science ®Google Scholar
• Rehm J, Room R, van den Brink W, Jacobi F. Alcohol use disorders in EU countries and Norway: An overview of the epidemiology. Eur Neuropsychopharmacol 2005; 15: 377–88
   PubMed Web of Science ®Google Scholar
• Kraus L, Augustin R, Frischer M, Kümmler P, Uhl A, Wiessing L. Estimating prevalence of problem drug use at national level in countries of the European Union and Norway. Addiction 2003; 98: 471–85
   PubMed Web of Science ®Google Scholar
• Modestin J, Nussbaumer C, Angst K, Scheidegger P, Hell D. Use of potentially abusive psychotropic substances in psychiatric inpatients. Eur Arch Psychiatry Clin Neurosci 1997; 247: 146–53
   PubMed Web of Science ®Google Scholar